-
Anxiety and freezing of gait: A new perspective for early intervention
-
Anxiety and parkinsonism signs in idiopathic REM sleep behavior disorder
-
Anxiety in patients with Parkinson’s disease
-
Anxiolytic-like activity of the adenosine A2A receptor antagonist, istradefylline (KW-6002) in rodent models of anxiety
-
Apathy and striatal dopamine defects in non-demented patients with Parkinson’s disease
-
Apathy phenotype in Parkinson’s disease: Motor and non-motor features
-
APL-130277 is a sublingual film being studied in phase 3 trials to rapidly turn patients ON from OFF episodes by delivering apomorphine via the oral mucosa
-
Apocyanin ameliorates post-stroke movement disorder in rats: Possible role of neurochemical and inflammatory alterations
-
Apolipoprotein E genotypes in Brazilian patients with Parkinson’s disease and their correlation with cognitive performance assessed by MoCA
-
Apomorphine treatment in advanced Parkinson’s disease (PD): Duration of treatment and safety experience in a managed care program in Germany
- « Previous Page
- 1
- …
- 15
- 16
- 17
- 18
- 19
- …
- 207
- Next Page »